Kenichi Serizawa
Kanagawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Anti-IL-6 Receptor Antibody Suppresses Visual Dysfunction in AQP4 Peptide-Immunized Mice.
Journal: Translational vision science & technology
Published: February 05, 2026
Serum from patients with MuSK antibody-positive myasthenia gravis triggers transcriptomic changes leading to muscle atrophy and weakness in human myotube cells.
Journal: Journal of neuroimmunology
Published: June 18, 2025
Serum from patients with acetylcholine receptor antibody-positive myasthenia gravis triggers pathogenic changes in human myotube cells.
Journal: Journal of neuroimmunology
Published: June 13, 2025
Aquaporin-4 Peptide Injection in Mice Induces Retinal and Optic Nerve Alterations That Simulate Those of Neuromyelitis Optica Spectrum Disorder.
Journal: Translational vision science & technology
Published: June 10, 2025
Anti-IL-6R antibody treatment changes microglial phenotype in AQP4 peptide-immunized mice, leading to suppression of myelitis severity.
Journal: Journal of neuroimmunology
Published: January 15, 2025
Anti-IL-6 receptor antibody suppresses onset of paralytic symptoms in AQP4 peptide-immunized mice without lowering bone strength or mineral density.
Journal: Journal of neuroimmunology
Published: December 03, 2024
IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model.
Journal: Frontiers in neurology
Published: December 15, 2023
Intradermal AQP4 peptide immunization induces clinical features of neuromyelitis optica spectrum disorder in mice.
Journal: Journal of neuroimmunology
Published: February 03, 2023
Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders.
Journal: Inflammation and regeneration
Published: May 31, 2021
New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 28, 2021
Prolonged Duration of Erythropoiesis-Stimulating Agents' Action Delays Disease Progression in Anti-Thy 1 Antibody-Induced Chronic Glomerulonephritis Rats.
Journal: Pharmacology
Published: October 10, 2019
Anti-IL-6 Receptor Antibody Inhibits Spontaneous Pain at the Pre-onset of Experimental Autoimmune Encephalomyelitis in Mice.
Journal: Frontiers in neurology
Published: December 28, 2018
Last Updated: 09/26/2026